Evidence map›Paper›PMID 41342119›Full record

ArticleCirculation research2026

CPT1a Expression Is a Critical Cardioprotective Response to Pathological Stress That Enables Rescue by Gene Transfer.

Andrew N Carley, Santosh K Maurya, Chandan K Maurya, Yang Wang, Amy Webb, Azariyas A Challa, Tatiana Gromova, Thomas M Vondriska, Zhentao Zhang, Hua Zhu and 7 more

Abstract read
In one paragraph

Article in Circulation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Endothelial SRSF1: A Key Regulator of Post-Ischemic Angiogenesis.Journal of cardiovascular translational research · 2026
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Andrew N CarleyDepartment of Internal Medicine (A.N.C., S.K.M., C.K.M., Y.W., A.A.C., E.D.L.), The Ohio State University College of Medicine, Columbus.
Santosh K MauryaDepartment of Internal Medicine (A.N.C., S.K.M., C.K.M., Y.W., A.A.C., E.D.L.), The Ohio State University College of Medicine, Columbus.
Chandan K MauryaDepartment of Internal Medicine (A.N.C., S.K.M., C.K.M., Y.W., A.A.C., E.D.L.), The Ohio State University College of Medicine, Columbus.ORCID 0000-0003-2581-7415
Yang WangDepartment of Internal Medicine (A.N.C., S.K.M., C.K.M., Y.W., A.A.C., E.D.L.), The Ohio State University College of Medicine, Columbus.ORCID 0009-0001-6671-5688
Amy WebbDepartment of Biomedical Informatics (A.W.), The Ohio State University, Columbus.
Azariyas A ChallaDepartment of Internal Medicine (A.N.C., S.K.M., C.K.M., Y.W., A.A.C., E.D.L.), The Ohio State University College of Medicine, Columbus.ORCID 0000-0001-7067-1692
Tatiana GromovaDepartments of Anesthesiology, Medicine and Physiology, University of California, Los Angeles (T.G., T.M.V.).ORCID 0000-0001-5597-2067
Thomas M VondriskaDepartments of Anesthesiology, Medicine and Physiology, University of California, Los Angeles (T.G., T.M.V.).ORCID 0009-0000-5238-1245
Zhentao ZhangDepartment of Surgery (Z.Z., H.Z.), The Ohio State University College of Medicine, Columbus.
Hua ZhuDepartment of Surgery (Z.Z., H.Z.), The Ohio State University College of Medicine, Columbus.ORCID 0000-0001-7136-7326
Ahlke HeydemannDepartment of Physiology and Biophysics, University of Illinois at Chicago (A.H.).ORCID 0000-0002-2626-3787
Kenneth C BediSmilow Translational Research Center, Cardiovascular Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia (K.C.B., K.B.M.).ORCID 0000-0003-3588-9324
Christos P KyriakopoulosNora Eccles Harrison Cardiovascular Research and Training Institute, The University of Utah, Salt Lake City (C.P.K., C.H.S., S.G.D.).ORCID 0000-0001-9415-1245
Craig H SelzmanNora Eccles Harrison Cardiovascular Research and Training Institute, The University of Utah, Salt Lake City (C.P.K., C.H.S., S.G.D.).ORCID 0000-0001-9218-4764
Stavros G DrakosNora Eccles Harrison Cardiovascular Research and Training Institute, The University of Utah, Salt Lake City (C.P.K., C.H.S., S.G.D.).ORCID 0000-0002-1223-327X
Kenneth B MarguliesSmilow Translational Research Center, Cardiovascular Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia (K.C.B., K.B.M.).ORCID 0000-0002-8093-4465
E Douglas LewandowskiDepartment of Internal Medicine (A.N.C., S.K.M., C.K.M., Y.W., A.A.C., E.D.L.), The Ohio State University College of Medicine, Columbus.ORCID 0000-0002-8970-9491

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
TRAINING IN CARDIOVASCULAR RESEARCHT32HL007576 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Stavros George Drakos, Robin M Shaw · 1985 to 2026
$10.6M
Dynamics of Cardiac Nuclei in Heart DiseaseR01HL105699 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VONDRISKA, THOMAS M. · 2011 to 2025
$5.0M
Adipose tissue mediates cardiac metabolic remodeling in the pathologically stressed heart in the absence of primary metabolic stressR01HL164290 · NHLBI · OHIO STATE UNIVERSITY · PI E DOUGLAS LEWANDOWSKI, Kristin I Stanford · 2023 to 2026
$3.1M
Transendothelial transport and CD36 in the dysregulated lipid trafficking of failing heartsR01HL160646 · NHLBI · OHIO STATE UNIVERSITY · PI LEWANDOWSKI, E DOUGLAS · 2022 to 2025
$2.8M
Maladaptive Expression of Metabolic Enzymes and Activity in Heart FailureR01HL132525 · NHLBI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI LEWANDOWSKI, E DOUGLAS · 2016 to 2019
$2.5M
Perm1 is a Novel Regulator of Cardiac Energetics and FunctionR01HL156667 · NHLBI · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI DRAKOS, STAVROS GEORGE, WARREN, JUNKO SHIBAYAMA · 2021 to 2024
$2.0M
Clinical and Metabolic Signature of Recovered Myocardium in Human Heart FailureR01HL135121 · NHLBI · UNIVERSITY OF UTAH · PI DRAKOS, STAVROS GEORGE · 2017 to 2021
$1.9M
Inhibiting Cell Death for Protecting Cardiac InjuryR01HL153876 · NHLBI · OHIO STATE UNIVERSITY · PI ZHU, HUA · 2020 to 2023
$1.6M
Postdoctoral Training in Cardiometabolic ScienceT32HL149637 · NHLBI · OHIO STATE UNIVERSITY · PI HSUEH, WILLA A, SMITH, SAKIMA AHMAD · 2020 to 2024
$1.5M
NCI NIH HHS P30 CA016058NHLBI NIH HHS R01 HL105699NHLBI NIH HHS R01 HL132525NHLBI NIH HHS R01 HL135121NHLBI NIH HHS R01 HL153876NHLBI NIH HHS R01 HL156667NHLBI NIH HHS R01 HL160646NHLBI NIH HHS R01 HL164290NHLBI NIH HHS T32 HL007576NHLBI NIH HHS T32 HL149637
6 · The paper itself

Abstract

backgroundCPT1 (carnitine palmitoyltransferase 1) is a rate-limiting enzyme for long-chain fatty acid oxidation. In adult hearts, CPT1b predominates, while CPT1a is coexpressed at lower levels. Pathological stress on the heart induces CPT1a expression, coinciding with a reduction in fatty acid oxidation, yet the role of CPT1a in pathological remodeling is unknown.

methodsCPT1 isoform expression was assayed in the myocardium of patients with heart failure with nonischemic cardiomyopathy and a preclinical mouse model of heart failure. Mice were subjected to afterload stress via transverse aortic constriction (TAC) or sham surgery (sham) with cardiac-specific CPT1a knockdown or cardiac-specific, adeno-associated virus serotype 9 (AAV9)-mediated CPT1a overexpression (AAV9.cTnT [cardiac troponin T].Cpt1a) versus empty virus or PBS infusions as controls. MicroRNA 370, known to suppress hepatic CPT1a, was assayed and overexpressed to determine if microRNA 370 regulates cardiac CPT1a expression.

resultsCPT1a protein was elevated and microRNA 370 reduced in the myocardium of male and female patients with nonischemic cardiomyopathy, as well as in failing mouse hearts. AAV9-mediated microRNA 370 overexpression in mouse hearts suppressed CPT1a expression and attenuated the response of CPT1a to TAC. Preventing CPT1a upregulation in response to TAC in cardiac-specific CPT1a knockout mice exacerbated adverse remodeling, severe dysfunction, and increased mortality. In contrast, CPT1a overexpression (2.8-fold) attenuated impaired ejection fraction (by 54%) versus control TAC hearts (

conclusionsThe effects of CPT1a in the heart extend beyond fatty acid oxidation including noncanonical regulation of gene programs. CPT1a upregulation occurs in nonischemic cardiomyopathy and is a critical cardioprotective adaptation to pathological stress.

Indexed as

CardiomyopathiesCarnitine O-PalmitoyltransferaseGenetic TherapyHeart FailureAnimalsDependovirusDisease Models, AnimalFemaleGene Transfer TechniquesHumansMaleMiceMice, Inbred C57BLMice, KnockoutMicroRNAsMiddle AgedCarnitine O-PalmitoyltransferaseCPT1A protein, humanMicroRNAscarnitine o-palmitoyltransferaseheart failuremetabolism

Identifiers

PMID41342119
PMCPMC12811910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.